RussiaBioLink LLC (ISO 13485:2016) is a resident of the Technopark of the Novosibirsk Akademgorodok. The company has been on the market for over 20 years. Main activities: (1) development of reagent kits for molecular diagnostics in oncology: - analysis of mutations in tumor cells to select the correct therapy; - analysis of circulating tumor DNA for early cancer diagnosis; - analysis of mutations associated with hereditary forms of cancer; - analysis of mutations associated with the formation of toxicity to chemotherapy drugs. (2) production of reagents for molecular genetic research, including re.